Increasing Impact of HPV Vaccination Seen in the United States
TUESDAY, May 17, 2022 -- The impact of human papillomavirus (HPV) vaccination is increasing in the United States, with evidence of herd protection, according to a study published online May 17 in the Annals of Internal Medicine. Hannah G.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2022 Category: Pharmaceuticals Source Type: news

Benefits of HPV Immunization Spilling Over to the Unvaxxed
(MedPage Today) -- Human papillomavirus (HPV) vaccination was associated with a 90% reduction in four types of cervical HPV infections in sexually active girls and young women, a cross-sectional study found. For unvaccinated females in the study... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 17, 2022 Category: Hematology Source Type: news

SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancer
The Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer after the completion of the phase 2/3 clinical trials to ensure its early availability in the country, official sources said (Source: The Economic Times)
Source: The Economic Times - May 15, 2022 Category: Consumer Health News Source Type: news

F.D.A. Authorizes Underwear to Protect Against S.T.I.s During Oral Sex
It ’s the first time underwear has been authorized for this purpose, and it provides a new choice for protection where the few options have been unpopular. (Source: NYT Health)
Source: NYT Health - May 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Sex Head and Neck Cancer Lingerie and Underwear Sexually Transmitted Diseases Women and Girls Mouth Vagina Human Papillomavirus (HPV) Food and Drug Administration your-feed-science your-feed-healthcare Source Type: news

Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Media News - May 12, 2022 Category: Pharmaceuticals Source Type: news

Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Investor Update - May 12, 2022 Category: Pharmaceuticals Source Type: news

Self-Collected Menstrual Blood to Detect HPV?
(MedPage Today) -- Self-collected menstrual blood samples offered "highly concordant" results with clinician-collected sampling in women who were positive for human papillomavirus (HPV), a researcher reported. In a small study of about 100 women... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 9, 2022 Category: Hematology Source Type: news

Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus
NEW BRUNSWICK, NJ, May 9, 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration and license agreements with Bavarian Nordic that leverage Bavarian Nordic’s MVA-BN® (Modified Vaccinia Ankara - Bavarian Nordic) technology to develop potential vaccines against the hepatitis B virus and human papillomaviruses. Janssen remains committed to its strong collaboration with Bavarian Nordic in the quest to prevent and cure infectious diseases – with collaborations in HIV and Ebola still ongoing.No clinical studies in hepatitis B have been initiated by Janssen ut...
Source: Johnson and Johnson - May 9, 2022 Category: Pharmaceuticals Source Type: news

Hope for cancer patients
University of Edinburgh researchers discovered the test, known as a liquid biopsy, can accurately predict if cancer caused by human papillomavirus (HPV) is going to come back. (Source: the Mail online | Health)
Source: the Mail online | Health - May 1, 2022 Category: Consumer Health News Source Type: news

Science Saturday: Uncovering disparities in local communities -- the case of the HPV vaccine
Where you live may affect whether you receive the cancer-preventing HPV vaccine, suggests a new study published in the journal Vaccine. The first human papillomavirus (HPV) vaccine was approved for use in the U.S. by the Food and Drug Administration in 2006. According to the National Cancer Institute, the types of HPV the current vaccine covers are those which cause 90% of genital warts, as many as 90% of cervical cancers, as well as a majority of oropharyngeal (a type of throat cancer), anal, penile, vaginal and vulvar cancers.… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 30, 2022 Category: Research Source Type: news

HPV: High-risk infections could trigger a cancerous tumour – what to look out for
HPV CAN be a dangerous infection, depending on which strain you come in contact with. Some human papillomavirus infections cause cell changes that can lead to cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - April 21, 2022 Category: Consumer Health News Source Type: news

Cervical cancer screening and prevention among survivors of intimate partner violence - Bagwell-Gray ME, Ramaswamy M.
Women who experience intimate partner violence are an underserved population at risk for cervical cancer, precipitated by their heightened risk for human papilloma virus (HPV) and underutilization of gynecological care. This pilot study describes the self-... (Source: SafetyLit)
Source: SafetyLit - March 24, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

HPV Vaccination May Be Cutting Cervical Cancer Rates
WEDNESDAY, March 16, 2022 -- The recent decrease in the incidence of cervical cancers, particularly in young women, may be associated with human papillomavirus (HPV) vaccination approval, according to a study published online March 16 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2022 Category: Pharmaceuticals Source Type: news

HPV-Associated Cancer Incidence Starting to Increase
FRIDAY, March 11, 2022 -- The incidence of human papillomavirus (HPV)-associated cancers is beginning to increase, with greater increases seen in the lowest-income counties and in counties with high smoking prevalence, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021
Basel, 3 February 2022Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilarsDiagnostics Divisionsales grow 29%; strong momentum in base business and continued high demand for COVID-19 testsMajor approvals for medicinessince the last quarter: United States: Susvimo and Vabysmo (age-related blindness)Europe: Gavreto (specific type of advanced lung cancer); Actemra/RoActemra (severe COVID-19); Ronapreve (non-hospitalised COVID-19 patients and prophylaxis)Major appro...
Source: Roche Investor Update - February 3, 2022 Category: Pharmaceuticals Source Type: news